The patentability of human embryonic stem cell technology in China

Yaojin Peng

doi:10.1038/nbt.3417

The patentability of human embryonic stem cell technology in China

Yaojin Peng^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Although China has in the past decade been reluctant to grant patents on human embryonic stem cell technology, it has recently changed its patent policy to loosen some restrictions.

Original language	English
Pages (from-to)	37-39
Number of pages	3
Journal	Nature Biotechnology
Volume	34
Issue number	1
Early online date	8 Jan 2016
DOIs	https://doi.org/10.1038/nbt.3417
Publication status	Published - Jan 2016

Access to Document

10.1038/nbt.3417

Cite this

@article{c9f02348a4dc458cbe5eac5d3eebff73,

title = "The patentability of human embryonic stem cell technology in China",

abstract = "Although China has in the past decade been reluctant to grant patents on human embryonic stem cell technology, it has recently changed its patent policy to loosen some restrictions.",

author = "Yaojin Peng",

year = "2016",

month = jan,

doi = "10.1038/nbt.3417",

language = "English",

volume = "34",

pages = "37--39",

journal = "Nature Biotechnology",

issn = "1087-0156",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - The patentability of human embryonic stem cell technology in China

AU - Peng, Yaojin

PY - 2016/1

Y1 - 2016/1

N2 - Although China has in the past decade been reluctant to grant patents on human embryonic stem cell technology, it has recently changed its patent policy to loosen some restrictions.

AB - Although China has in the past decade been reluctant to grant patents on human embryonic stem cell technology, it has recently changed its patent policy to loosen some restrictions.

U2 - 10.1038/nbt.3417

DO - 10.1038/nbt.3417

M3 - Article

SN - 1087-0156

VL - 34

SP - 37

EP - 39

JO - Nature Biotechnology

JF - Nature Biotechnology

IS - 1

ER -